Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|December 5, 2019
Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16- High Risk Head and Neck CancerYue Cao, Madhava Aryal, Pin Li, et al.
The Laryngoscope|December 21, 2011
Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancerDerrick Wansom, Emily Light, Dafydd Thomas, et al.
Head & Neck|May 1, 2016
ACR Appropriateness criteria® for nasopharyngeal carcinomaNabil F Saba, Joseph K Salama, Jonathan J Beitler, et al.
Oral Oncology|May 15, 2014
ACR Appropriateness Criteria® thyroid carcinomaJoseph K Salama, Daniel W Golden, Sue S Yom, et al.
The Lancet. Oncology|July 29, 2019
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trialDouglas Adkins, Jessica Ley, Prakash Neupane, et al.
Head & Neck|June 5, 2013
Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictorsKlaudia U Hunter, Oliver E Lee, Teresa H Lyden, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2019
Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical CarcinomaLaila A Gharzai, Michael D Green, Kent A Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2023
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic CarcinomaGlenn J Hanna, Myung-Ju Ahn, Jameel Muzaffar, et al.
Head & Neck|June 23, 2016
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomasJonathan J Beitler, Harry Quon, Christopher U Jones, et al.
Endocrine-Related Cancer|September 16, 2015
Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancerFrancis Worden, Martin Fassnacht, Yuankai Shi, et al.
Pageof 7